# Pharmacokinetic Interactions Between Hemay005 Tablets and Midazolam Maleate Tablets

> **NCT06610890** · PHASE1 · COMPLETED · sponsor: **Ganzhou Hemay Pharmaceutical Co., Ltd** · enrollment: 20 (actual)

## Conditions studied

- Psoriasis

## Interventions

- **DRUG:** Hemay005
- **DRUG:** Midazolam maleate

## Key facts

- **NCT ID:** NCT06610890
- **Lead sponsor:** Ganzhou Hemay Pharmaceutical Co., Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-12-12
- **Primary completion:** 2025-01-20
- **Final completion:** 2025-01-20
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2025-12-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06610890

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06610890, "Pharmacokinetic Interactions Between Hemay005 Tablets and Midazolam Maleate Tablets". Retrieved via AI Analytics 2026-07-08 from https://api.ai-analytics.org/clinical/NCT06610890. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*